MABXIENCE RESEARCH SL.
Location
Madrid
Founded
2015-12-23
Website
Risk Signals
28 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Strategic Partnerships (19)
New Product Release (7)
Business Launches (4)
Biodiversity Conservation (3)
Renewable Energy Innovations (3)
Strategic Alliances (3)
Healthcare Compliance and Regulations (3)
Acquisition Announcements (3)
Executive Leadership Changes (2)
Business Agreements (2)
Cross-Border Mergers (2)
Economic Indicators (1)
Microfinance and SME Lending (1)
Corporate Social Responsibility Initiatives (1)
Private Equity Buyouts (1)
Real Estate Projects (1)
Consumer Purchasing Trends (1)
Startup Launches (1)
Business Growth Initiatives (1)
Artificial Intelligence Developments (1)
Sustainable Industry Practices (1)
Recent Articles about MABXIENCE RESEARCH SL.
Live alerts from global media, monitored by Business Radar
2022-04-14 (biospace.com)
Roche Wakes Up to New Competition as FDA Approves Amneal's Avastin Biosimilar -
Amneal Pharmaceuticals received the green light from the U.S. Food and Drug Administration for bevacizumab-maly, a biosimilar to Genentech (Roche)'s Avastin.
Read more